This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rehm, S. Articles by Rice, J. M. Search for Related Content PubMed PubMed Citation Articles by Rehm, S. Articles by Rice, J. M.

Mouse Papillary Lung Tumors Transplacentally Induced by N-Nitrosoethylurea: Evidence for Alveolar Type II Cell Origin by Comparative Light Microscopic, Ultrastructural, and Immunohistochemical Studies¹

Tumor Pathology and Pathogenesis Section and Perinatal Carcinogenesis Section, Laboratory of Comparative Carcinogenesis, Division of Cancer Etiology, National Cancer Institute, Frederick, Maryland 21701; Department of Anatomy and Embryology, University of Leiden, Leiden, The Netherlands; and Department of Pathology, University of Pittsburgh, Veterans Administration Medical Center, School of Medicine, Pittsburgh, Pennsylvania 15261

A histogenetic study was designed to evaluate controversial findings on the cell of origin of tubular/papillary lung tumors in mice, i.e., bronchiolar Clara cell versus alveolar type II cell. N-Nitrosoethylurea (0.5 mmol or 0.74 mmol/kg) was given to pregnant C3H (C3H/HeNCr MTV^-) and Swiss Webster [Tac:(SW)fBR] mice as a single i.p. injection on Day 14, 15, 16, or 18 of gestation. The offspring were studied at various ages ranging from 7 days to 52 wk.

Serial sections of the whole lung (100 to 200 sections per mouse) showed that solid/alveolar and papillary tumors arose from the pulmonary acinus, invading the bronchioles only as the tumors grew. Furthermore, a mixture of solid and papillary patterns within a single nodule did not represent a merging of two tumors but a progression from the solid to the papillary form. By use of two rabbit antisera against mouse lung surfactant apoproteins found in normal alveolar type II cells, it was shown by the avidin-biotin peroxidase complex procedure, by the peroxidase-antiperoxidase technique, and by indirect immunofluorescence that both solid and papillary tumors contained these proteins that are specific markers for alveolar type II cells. With a rabbit anti-rat Clara cell antiserum, none of the tumors studied was immunoreactive while normal Clara cells were reactive. The nitroblue tetrazolium formazan stain for dehydrogenase enzymes, found particularly in Clara cells, did not reveal these enzymes in any lung tumors from either strain.

Ultrastructurally, no typical features of the mature Clara cell were detected in papillary or other pulmonary neoplasms. However, all tumors showed characteristic alveolar type II cell structures such as various stages of lamellar body formation, although these features were less well differentiated in the papillary tumors. Argentaffin dense bodies, representing lysosomes and immature forms of lamellar bodies, were commonly observed in papillary tumors. Some features of the papillary tumors such as cell shape, high glycogen content, and primary cilia were equivalent to those seen in pulmonary epithelial precursor cells during fetal development. With age, the papillary tumors became invasive, accumulated neutral lipids, and developed bizarre cleaved nuclei and lamellated nuclear pseudoinclusions.

In conclusion, the papillary lung tumors of the mouse, at least those induced transplacentally by N-nitrosoethylurea, constitute less well-differentiated or poorly differentiated alveolar type II cell adenomas or carcinomas with fetal morphological and biochemical properties.

¹ Supported in part by USPHS Contracts N01-CO-23910 and N10-CP-41014 to Program Resources, Inc., and Microbiological Associates, Inc., respectively.

² To whom requests for reprints should be addressed, at National Cancer Institute, FCRF Bldg. 538, Room 220, Frederick, MD 21701-1013.

Received 7/ 2/87. Revised 9/29/87. Accepted 10/ 5/87.

This article has been cited by other articles:

				A. Yu. Nikitin, A. Alcaraz, M. R. Anver, R. T. Bronson, R. D. Cardiff, D. Dixon, A. E. Fraire, E. W. Gabrielson, W. T. Gunning, D. C. Haines, et al. Classification of Proliferative Pulmonary Lesions of the Mouse: Recommendations of the Mouse Models of Human Cancers Consortium Cancer Res., April 1, 2004; 64(7): 2307 - 2316. [Abstract] [Full Text] [PDF]

				A. K. Bauer, L. D. Dwyer-Nield, and A. M. Malkinson High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors Carcinogenesis, April 1, 2000; 21(4): 543 - 550. [Abstract] [Full Text] [PDF]

				R. J. Mason, M. Kalina, L. D. Nielsen, A. M. Malkinson, and J. M. Shannon Surfactant Protein C Expression in Urethane-Induced Murine Pulmonary Tumors Am. J. Pathol., January 1, 2000; 156(1): 175 - 182. [Abstract] [Full Text] [PDF]

				L. M. Montuenga, J. Zhou, I. Avis, M. Vos, A. Martinez, F. Cuttitta, A. M. Treston, M. Sunday, and J. L. Mulshine Expression of Heterogeneous Nuclear Ribonucleoprotein A2/B1 Changes with Critical Stages of Mammalian Lung Development Am. J. Respir. Cell Mol. Biol., October 1, 1998; 19(4): 554 - 562. [Abstract] [Full Text]

				G. Singh and S. L. Katyal Clara Cells and Clara Cell 10 kD Protein (CC10) Am. J. Respir. Cell Mol. Biol., August 1, 1997; 17(2): 141 - 143. [Full Text]